This bill would prohibit the Food and Drug Administration from approving or maintaining approval of abortion drugs if the agency treated pregnancy as an illness in its decision-making process. The legislation specifically targets mifepristone, a medication used for medication abortion, and would nullify its current FDA approval retroactively. The bill would prevent the FDA from using pregnancy-related factors as a basis for approving abortion medications or imposing safety requirements on them going forward. No funding or implementation timeline is specified in the legislation. The bill would effectively restrict federal authority over abortion drug regulation and applies to the Department of Health and Human Services and FDA.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.